HomeRGNX • NASDAQ
add
Regenxbio Inc
Previous close
$8.36
Day range
$7.96 - $8.37
Year range
$5.62 - $22.81
Market cap
408.25M USD
Avg Volume
889.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 21.21M | -4.50% |
Operating expense | 224.41M | -9.43% |
Net income | -51.19M | 18.61% |
Net profit margin | -241.28 | 14.78% |
Earnings per share | -1.01 | 29.37% |
EBITDA | -47.34M | 15.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 234.69M | -14.74% |
Total assets | 465.99M | -18.81% |
Total liabilities | 206.34M | -21.31% |
Total equity | 259.65M | — |
Shares outstanding | 50.09M | — |
Price to book | 1.60 | — |
Return on assets | -26.07% | — |
Return on capital | -30.27% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -51.19M | 18.61% |
Cash from operations | -31.62M | 22.41% |
Cash from investing | 40.27M | 18.54% |
Cash from financing | -7.74M | 35.30% |
Net change in cash | 909.00K | 104.85% |
Free cash flow | -18.21M | -1.08% |
About
Founded
2008
Headquarters
Website
Employees
353
